enGene Holdings Inc. Common Stock (ENGN) Stock Analysis

enGene Holdings Inc. Common Stock (ENGN) is a publicly traded company in the HEALTHCARE sector. It trades at $1.74, carries a market capitalization of $119.24M. This page summarizes the public market data, fundamentals, and frequently asked questions for ENGN, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.74
• Market Cap: $119.24M
• EPS: $-2.25
• 52-Week High: $12.25
• 52-Week Low: $1.40

Market Sentiment

enGene Holdings Inc. Common Stock currently has a Neutral sentiment score of 0.07.

About enGene Holdings Inc. Common Stock

enGene Holdings Inc. is a clinical-stage biotechnology firm headquartered in Saint-Laurent, Canada, focused on pioneering genetic medicines for the targeted treatment of diseases affecting mucosal tissues and other organs. The company employs cutting-edge delivery technologies to improve the efficacy and safety of its proprietary therapeutic platform, addressing critical unmet medical needs in the field of genetic therapy. With its promising pipeline advancing through clinical trials, enGene ...

GNG Research Analysis

GNG Research scores enGene Holdings Inc. Common Stock (ENGN) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for ENGN.

Frequently Asked Questions

Does ENGN pay dividends?

enGene Holdings Inc. Common Stock (ENGN) does not currently pay a regular dividend.

What is ENGN's market cap?

enGene Holdings Inc. Common Stock (ENGN) has a market capitalization of $119.24M with a current stock price of $1.74.